US 7619005
Methods for treating cognitive impairment in humans with Multiple Sclerosis
granted A61KA61K31/137A61K31/4458
Quick answer
US patent 7619005 (Methods for treating cognitive impairment in humans with Multiple Sclerosis) held by Cognition Pharmaceuticals, LLC expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cognition Pharmaceuticals, LLC
- Grant date
- Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/137, A61K31/4458